Johnson & Johnson to help support India’s efforts to end TB by 2025
Through a series of new collaborations with several multilateral and non-governmental organizations (NGOs), as well as the Government of India, J&J aims to help support the country's efforts to end TB by 2025
Gilead, Glympse Bio collaborate on use of biomarker technology in NASH Clinical Development
Glympse Bio’s synthetic biomarkers will be used to determine clinical trial participants’ stage of disease to determine responses to treatment in Gilead’s NASH clinical program.
Global Health Progress launched to drive cross-sectoral collaborations in meeting sustainable goals
Global Health Progress is a new knowledge hub highlighting over 200 collaborations between the biopharmaceutical industry and more than 850 partners to support the SDGs.